4//SEC Filing
MUELLER ALAN L 4
Accession 0001235645-04-000005
CIK 0000890465other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 6:07 PM ET
Size
7.9 KB
Accession
0001235645-04-000005
Insider Transaction Report
Form 4
MUELLER ALAN L
VP, Drug Discovery
Transactions
- Award
Incentive Stock Option
2004-05-20$21.73/sh+3,661$79,554→ 3,661 totalExercise: $21.73From: 2005-05-20Exp: 2014-05-20→ Common Stock (3,661 underlying) - Award
Non-Qualified Stock Option
2004-05-20$21.73/sh+16,339$355,046→ 16,339 totalExercise: $21.73From: 2005-05-20Exp: 2014-05-20→ Common Stock (16,339 underlying)
Footnotes (1)
- [F1]Stock option granted under the 1998 Stock Option Plan. The option becomes exercisable based on the following four-year vesting schedule: 28% on the first anniversary of the grant, and 2% each month thereafter.
Documents
Issuer
NPS PHARMACEUTICALS INC
CIK 0000890465
Entity typeother
Related Parties
1- filerCIK 0001235645
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 6:07 PM ET
- Size
- 7.9 KB